Skip to main content
placeholder image

A phase I trial of AEG35156 (XIAP antisense) administered as a continuous intravenous infusion in patients with advanced tumors

Journal Article


Abstract


Publication Date


  • 2006

Citation


  • Ranson, M., Dive, C., Ward, T., Cummings, J., Connolly, K., Evans, S., . . . Jodrell, D. (2006). A phase I trial of AEG35156 (XIAP antisense) administered as a continuous intravenous infusion in patients with advanced tumors. Journal of Clinical Oncology, 24(18_suppl), 3059. doi:10.1200/jco.2006.24.18_suppl.3059

Web Of Science Accession Number


Start Page


  • 3059

End Page


  • 3059

Volume


  • 24

Issue


  • 18_suppl

Abstract


Publication Date


  • 2006

Citation


  • Ranson, M., Dive, C., Ward, T., Cummings, J., Connolly, K., Evans, S., . . . Jodrell, D. (2006). A phase I trial of AEG35156 (XIAP antisense) administered as a continuous intravenous infusion in patients with advanced tumors. Journal of Clinical Oncology, 24(18_suppl), 3059. doi:10.1200/jco.2006.24.18_suppl.3059

Web Of Science Accession Number


Start Page


  • 3059

End Page


  • 3059

Volume


  • 24

Issue


  • 18_suppl